Related Experiment Videos
Upregulated CircRNAs With Efficacy in Preclinical In Vivo Models Reveal New Targets for Therapeutic Intervention in
Satu Nahkuri1, Ulrich H Weidle2
1Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland; satu.nahkuri@roche.com.
Abstract:
There is a significant need to improve treatment efficacy for patients with glioma. Therefore, we have analyzed the literature for the role of circular RNAs (circRNAs) with respect to selected pathology-related topics of glioma. We have focused on upregulated circRNAs with efficacy in preclinical in vivo models. The identified circRNAs cover the following topics: Temozolomide (TMZ) resistance, transmembrane and secreted proteins, wingless-related integration site (WNT) signaling, cytoskeleton dynamics, cell-cell and cell-extracellular matrix interactions, as well as circRNAs with additional functions. We describe possible therapeutic tools and challenges with respect to delivery of the corresponding inhibitory agents.
Insights
Circular RNAs (circRNAs) show promise in overcoming glioma treatment resistance. This review highlights upregulated circRNAs targeting key pathways and discusses therapeutic delivery challenges for improved glioma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma treatment efficacy requires improvement.
- Circular RNAs (circRNAs) are implicated in various cancers.
- Upregulated circRNAs in glioma present potential therapeutic targets.
Purpose of the Study:
- To review the literature on upregulated circRNAs in glioma.
- To identify circRNAs affecting glioma pathology and treatment resistance.
- To explore therapeutic strategies involving circRNAs for glioma.
Main Methods:
- Literature analysis of circRNAs in glioma.
- Focus on upregulated circRNAs with preclinical efficacy.
- Categorization of circRNAs by associated biological processes.
Main Results:
- Identified circRNAs associated with Temozolomide (TMZ) resistance.
- CircRNAs influencing transmembrane/secreted proteins and WNT signaling were noted.
- CircRNAs involved in cytoskeleton dynamics and cell-matrix interactions were found.
Conclusions:
- Upregulated circRNAs represent promising therapeutic targets for glioma.
- Further research into circRNA functions and delivery is crucial.
- Development of targeted therapies using circRNAs could enhance glioma treatment outcomes.